# EDGAR Filing Document

**Accession Number:** 0002027329
**File Stem:** 0001193125-26-229777
**Filing Date:** 2026-5
**Character Count:** 4147
**Document Hash:** 366965a38fa818ee34d5d6be3b3a64aa
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-229777.hdr.sgml**: 20260519

**ACCESSION NUMBER**: 0001193125-26-229777

**CONFORMED SUBMISSION TYPE**: 8-A12B

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260519

**DATE AS OF CHANGE**: 20260519

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Optimi Health Corp.
- **CENTRAL INDEX KEY:** 0002027329
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** A1
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** 8-A12B
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-43304
- **FILM NUMBER:** 26996034

**BUSINESS ADDRESS:**
- **STREET 1:** UNIT 600, 21 WATER STREET
- **CITY:** VANCOUVER
- **STATE:** A1
- **ZIP:** V6B 1A1
- **BUSINESS PHONE:** 6043770403

**MAIL ADDRESS:**
- **STREET 1:** UNIT 600, 21 WATER STREET
- **CITY:** VANCOUVER
- **STATE:** A1
- **ZIP:** V6B 1A1

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

**FORM 8-A** 

**FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES** 

**PURSUANT TO SECTION 12(b) OR (g) OF** 

**THE SECURITIES EXCHANGE ACT OF 1934** 

## OPTIMI HEALTH CORP.
**(Exact name of registrant as specified in its charter)** 

---

| | |
|:---|:---|
| **British Columbia** | **Not Applicable** |
| **(State or other jurisdiction of**<br> **incorporation or organization)** | **(I.R.S. Employer**<br> **Identification No.)** |

---

**269 David Brown Way** 

**Princeton, B.C. V0X 1W0** 

**Canada** 

**(Address of principal executive offices)** 

**Securities to be registered pursuant to Section 12(b) of the Act:** 

---

| | |
|:---|:---|
| **Title of each class**<br> **to be registered** | **Name of each exchange on which**<br> **each class is to be registered** |
| **Common Shares, with no par value** | **The Nasdaq Stock Market LLC** |

---

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box. ☒

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box. ☐

If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. ☐

**Securities Act registration statement file number to which this form relates: 333-290086.** 

**Securities to be registered pursuant to Section 12(g) of the Act: None** 

------

**Item 1. Description of Registrant's Securities to be Registered.** 

The description of the securities to be registered is contained in a prospectus that forms a part of the registrant's registration statement on Form F-1 (File No. 333-290086) initially filed with the U.S. Securities and Exchange Commission on September 5, 2025 relating to such securities and is to be filed pursuant to Rule 424(b) under the Securities Act of 1933, as amended (such prospectus as filed pursuant to Rule 424(b), the "Prospectus"). The description of the securities contained in the Prospectus is hereby incorporated by reference into this Form 8-A. Copies of such description will be filed with The Nasdaq Stock Market LLC.

**Item 2. Exhibits.** 

No exhibits are required to be filed as the securities being registered on this form (1) are being registered on an exchange on which no other securities of the registrant are registered and (2) are not being registered pursuant to Section 12(g) of the Exchange Act.

------

**SIGNATURE** 

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

---

| | |
|:---|:---|
| **Optimi Health Corp.** | **Optimi Health Corp.** |
| Date: May 19, 2026 | Date: May 19, 2026 |
| By: | /s/ Dane Stevens |
| Name: | Dane Stevens |
| Title: | Chief Executive Officer, Chief Marketing Officer and Director |

---